Actelion
Pharmaceutical ManufacturingBasel-stadt, Switzerland201-500 Employees
We're now part of Janssen. For future updates, please visit our LinkedIn channel: 'Janssen Pharmaceutical Companies of Johnson & Johnson'. #WithYouUntilPHIsnt
Strategic R&D Collaborations Janssen actively partners with academic institutions and biotech companies worldwide, indicating opportunities for suppliers or service providers specializing in research tools, collaborative platforms, or innovation management solutions to support their ongoing clinical and scientific projects.
Focus on Emerging Therapies The company's recent collaborations with firms working on oligonucleotide analysis and small-molecule medicines suggest potential for suppliers offering advanced biotech reagents, analytical instruments, or manufacturing technologies tailored to cutting-edge therapeutic development.
Social and Educational Engagement Janssen's community initiatives, such as mental health projects with universities and mentorship programs for women in healthcare, present opportunities for wellness, education, and engagement service providers eager to align with their corporate social responsibility strategies.
Technology Integration The use of diverse workplace technologies including Microsoft SharePoint, Genesys Cloud, and accessiBe highlights a modern, digitally integrated environment, opening doors for vendors offering enterprise software, digital transformation services, or analytics solutions to enhance operational efficiency.
Market and Regulatory Focus Recent legal and compliance challenges related to marketing practices emphasize potential opportunities for firms providing compliance consulting, legal technology solutions, or audit services to support Janssen’s efforts in risk management and regulatory adherence.
Actelion uses 8 technology products and services including accessiBe, Como, Microsoft SharePoint, and more. Explore Actelion's tech stack below.
| Actelion Email Formats | Percentage |
| First.Last@actelion.com | 42% |
| FLast@actelion.com | 9% |
| LastF@actelion.com | 4% |
| LastFirst@actelion.com | 4% |
| Last.First@actelion.com | 3% |
| First_Last@actelion.com | 3% |
| First-Last@actelion.com | 2% |
| FirstLast@actelion.com | 3% |
| F_Last@actelion.com | 2% |
| FiLast@actelion.com | 2% |
| FirstLas@actelion.com | 3% |
| First.L@actelion.com | 1% |
| LastFir@actelion.com | 2% |
| Last_First@actelion.com | 2% |
| Last.F@actelion.com | 2% |
| First-L@actelion.com | 2% |
| L.First@actelion.com | 1% |
| F.Last@actelion.com | 2% |
| FirLast@actelion.com | 1% |
| First_L@actelion.com | 2% |
| LastFi@actelion.com | 1% |
| FirstL@actelion.com | 1% |
| LFirst@actelion.com | 2% |
| F-Last@actelion.com | 1% |
| FirstLa@actelion.com | 1% |
| First.Middle@actelion.com | 1% |
| FirstMLast@actelion.com | 1% |
| First_Last@janssen.com | 42% |
| First.Last@janssen.com | 30% |
| FLast@janssen.com | 18% |
| First@janssen.com | 10% |
Pharmaceutical ManufacturingBasel-stadt, Switzerland201-500 Employees
We're now part of Janssen. For future updates, please visit our LinkedIn channel: 'Janssen Pharmaceutical Companies of Johnson & Johnson'. #WithYouUntilPHIsnt
Actelion's revenue is estimated to be in the range of $1B$10B
Actelion's revenue is estimated to be in the range of $1B$10B